|
UY26942A1
(es)
|
2000-09-20 |
2002-04-26 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
|
US20020055631A1
(en)
|
2000-09-20 |
2002-05-09 |
Augeri David J. |
N-acylsulfonamide apoptosis promoters
|
|
WO2005049593A2
(en)
|
2003-11-13 |
2005-06-02 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
BRPI0514504A
(pt)
|
2004-08-20 |
2008-06-10 |
Univ Michigan |
pequenas moléculas inibidoras de membros da famìlia bcl-2 anti-apoptóticos e os usos das mesmas
|
|
ES2493466T3
(es)
|
2005-05-12 |
2014-09-11 |
Abbvie Bahamas Ltd. |
Promotores de la apoptosis
|
|
EP1888543B1
(en)
|
2005-05-24 |
2012-08-01 |
Abbott Laboratories |
Apoptosis promoters
|
|
MX2009002422A
(es)
|
2006-09-05 |
2009-03-20 |
Abbott Lab |
Inhibidores bcl para tratar exceso de plaquetas.
|
|
WO2009036051A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Bcl-2 inhibitors containing a zinc binding moiety
|
|
US8501992B2
(en)
|
2008-06-09 |
2013-08-06 |
Bristol-Myers Squibb Company |
Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors
|
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
|
NZ614305A
(en)
|
2008-12-05 |
2015-03-27 |
Abbvie Inc |
Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
|
US8563735B2
(en)
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
|
CN102307862A
(zh)
|
2008-12-08 |
2012-01-04 |
贝林格尔.英格海姆国际有限公司 |
用于治疗癌症的化合物
|
|
NZ616828A
(en)
|
2009-01-19 |
2015-03-27 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
RU2538965C2
(ru)
|
2009-01-19 |
2015-01-10 |
Эббви Инк. |
Вызывающие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний
|
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
ES2546294T7
(es)
|
2009-05-26 |
2024-06-06 |
Abbvie Ireland Unlimited Co |
Agentes inductores de la apoptosis para el tratamiento de cáncer y enfermedades inmunitarias y autoinmunitarias
|
|
BR112012005343A2
(pt)
|
2009-09-10 |
2016-03-22 |
Novartis Ag |
sulfonamidas como inibidores de proteínas da família bcl-2 para o tratamento de câncer
|
|
AU2011229862B2
(en)
|
2010-03-25 |
2014-07-24 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
|
TWI535712B
(zh)
|
2010-08-06 |
2016-06-01 |
阿斯特捷利康公司 |
化合物
|
|
KR20180059560A
(ko)
|
2010-10-29 |
2018-06-04 |
애브비 인코포레이티드 |
아폽토시스―유도제를 포함하는 고체 분산체
|
|
IT1403156B1
(it)
|
2010-12-01 |
2013-10-04 |
Università Degli Studi Di Torino |
Inibitori di fosfatidilinositol 3-chinasi, relative composizioni ed usi.
|
|
KR101762724B1
(ko)
|
2011-01-25 |
2017-07-28 |
더 리젠츠 오브 더 유니버시티 오브 미시건 |
Bcl-2/bcl-xl 억제제 및 이를 이용한 치료 방법
|
|
CN103732589B
(zh)
|
2011-05-25 |
2016-03-30 |
百时美施贵宝公司 |
可用作抗细胞凋亡bcl抑制剂的取代的磺酰胺
|
|
WO2013053045A1
(en)
|
2011-10-12 |
2013-04-18 |
Beta Pharma Canada Inc. |
Heterocyclic molecules as apoptosis inducers
|
|
JP2015507741A
(ja)
|
2011-12-22 |
2015-03-12 |
サン−ゴバン セラミックス アンド プラスティクス，インコーポレイティド |
蓄積蛍光体粉末を含む画像蓄積装置、画像蓄積装置の形成方法、およびコンピューテッドラジオグラフィ装置
|
|
AU2012355624A1
(en)
|
2011-12-23 |
2014-07-17 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
|
AU2012355613A1
(en)
|
2011-12-23 |
2014-07-17 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
|
CA2859873A1
(en)
|
2011-12-23 |
2013-06-27 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
|
EA201491265A1
(ru)
|
2011-12-23 |
2014-11-28 |
Новартис Аг |
Соединения для ингибирования взаимодействия bcl-2 с партнерами по связыванию
|
|
WO2013185202A1
(en)
|
2012-06-14 |
2013-12-19 |
Beta Pharma Canada Inc |
Apoptosis inducers
|
|
EP2945940B1
(en)
|
2013-01-16 |
2020-07-15 |
The Regents of The University of Michigan |
Bcl-2/bcl-xl inhibitors and their use in the treatment of cancer
|
|
US20140275082A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
PL2989106T3
(pl)
|
2013-04-25 |
2017-08-31 |
Beigene, Ltd. |
Połączone związki heterocykliczne jako inhibitory kinazy białkowej
|
|
WO2015061752A1
(en)
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
SMT202100674T1
(it)
|
2014-08-11 |
2022-01-10 |
Acerta Pharma Bv |
Combinazioni terapeutiche di un inibitore di btk e un inibitore di bcl-2
|
|
WO2017132474A1
(en)
|
2016-01-30 |
2017-08-03 |
Newave Pharmaceutical Inc. |
Bcl-2 inhibitors
|
|
EP3481397A1
(en)
|
2016-07-06 |
2019-05-15 |
Concert Pharmaceuticals Inc. |
Deuterated venetoclax
|
|
KR102376764B1
(ko)
|
2016-08-05 |
2022-03-18 |
더 리젠츠 오브 더 유니버시티 오브 미시건 |
Bcl-2 억제제로서의 n-(페닐설포닐)벤즈아미드 및 관련 화합물
|
|
CN109641897B
(zh)
|
2016-09-01 |
2021-12-07 |
北京赛林泰医药技术有限公司 |
Bcl-2选择性抑制剂及其制备和用途
|
|
CN106565706B
(zh)
|
2016-10-27 |
2018-05-01 |
广东东阳光药业有限公司 |
一种磺酰胺衍生物及其在药学中的应用
|
|
CN106749233B
(zh)
*
|
2016-11-24 |
2020-04-21 |
中山大学 |
一类磺酰胺衍生物及其应用
|
|
CN108046014B
(zh)
*
|
2017-01-03 |
2019-06-18 |
惠州市盈晖电子有限公司 |
一种多种厚度规格的新旧smt接料带的粘接机
|
|
CN110177788B
(zh)
|
2017-01-07 |
2023-03-24 |
重庆复创医药研究有限公司 |
作为bcl-2选择性凋亡诱导剂的化合物
|
|
SI3612531T1
(sl)
|
2017-04-18 |
2022-11-30 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Sredstva, ki sprožajo apoptozo
|
|
JP7374496B2
(ja)
|
2017-06-26 |
2023-11-07 |
深▲チェン▼市塔吉瑞生物医薬有限公司 |
Ｂｃｌ－２タンパク質を阻害するためのＮ－ベンゼンスルホニルベンズアミド系化合物、その組成物および使用
|
|
MX2020002032A
(es)
|
2017-08-23 |
2020-09-17 |
Guangzhou Lupeng Pharmaceutical Company Ltd |
Inhibidores de bcl-2.
|
|
FR3072679B1
(fr)
|
2017-10-25 |
2020-10-30 |
Servier Lab |
Nouveaux derives macrocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
CN110143974B
(zh)
|
2018-02-11 |
2021-07-13 |
中国科学院上海药物研究所 |
一类新型青蒿素衍生物、合成方法及其用途
|
|
CN112437772B
(zh)
|
2018-04-29 |
2023-11-21 |
百济神州有限公司 |
Bcl-2抑制剂
|
|
CA3095699A1
(en)
|
2018-07-31 |
2020-02-06 |
Ascentage Pharma (Suzhou) Co., Ltd. |
Combination product of bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases
|
|
CN110772521A
(zh)
|
2018-07-31 |
2020-02-11 |
苏州亚盛药业有限公司 |
Bcl-2抑制剂或Bcl-2/Bcl-xL抑制剂与BTK抑制剂的组合产品及其用途
|
|
WO2020140005A2
(en)
*
|
2018-12-29 |
2020-07-02 |
Newave Pharmaceutical Inc. |
Bcl-2 inhibitors
|
|
WO2021083135A1
(en)
|
2019-10-28 |
2021-05-06 |
Beigene, Ltd. |
Bcl-2 INHIBITORS
|
|
WO2021110102A1
(en)
|
2019-12-02 |
2021-06-10 |
Beigene, Ltd. |
Methods of cancer treatment using bcl-2 inhibitor
|
|
CN116969937B
(zh)
*
|
2020-04-15 |
2026-03-24 |
百济神州(苏州)生物科技有限公司 |
Bcl-2抑制剂
|
|
CN116981668A
(zh)
*
|
2021-04-09 |
2023-10-31 |
百济神州(北京)生物科技有限公司 |
制备bcl-2抑制剂的中间体的方法
|
|
MX2023014275A
(es)
|
2021-06-02 |
2024-03-06 |
Beigene Switzerland Gmbh |
Métodos de tratamiento de la malignidad de células b utilizando un inhibidor de bcl-2.
|
|
MX2024002465A
(es)
|
2021-08-31 |
2024-04-29 |
Beigene Ltd |
Formas solidas de inhibidores de bcl-2, metodo de preparacion y sus usos.
|
|
TW202400163A
(zh)
|
2022-05-12 |
2024-01-01 |
英屬開曼群島商百濟神州有限公司 |
使用ｂｃｌ－２抑制劑治療髓性惡性腫瘤之方法
|
|
KR20250079128A
(ko)
|
2022-07-21 |
2025-06-04 |
베이진 스위찰랜드 게엠베하 |
Bcl-2 저해제를 사용한 다발성 골수종의 치료 방법
|